Shire receives FDA approval for new state-of-the-art plasma manufacturing facility
Shire announced the FDA) has approved the company’s first submission for its new plasma manufacturing facility near Covington, Georgia for the production of GAMMAGARD LIQUID® [Immune Globulin Infusion (Human)] 10% Solution, a replacement therapy for primary humoral immunodeficiency. June 21, 2018